The "bench to bedside" concept, harnessing knowledge from basic sciences to produce "new approaches for prevention, diagnosis and treatment of diseases" in clinical settings [1] implies a connection between basic scientists and clinicians [2].
Clinical and Translational Medicine encourages publishing scientific collaborations between basic scientists and clinical investigators with the requisite skills to design longitudinal studies and deal with regulatory and human-protection complexities.
It is, therefore, absolutely necessary for the field to move forward to increase the collaboration between basic scientists and clinicians in order to overcome the hurdles linked with the development of quantitative imaging biomarkers.
(11) Therefore, translational research requires a close collaboration between basic scientists and clinical researchers, as well as between academia and industry.
We envision the following: Improved communication between basic scientists and ICU physicians will enhance translational research and lead to the development of preclinical models that are more clinically relevant.
Our report presents the results of a collaborative effort between basic scientists and clinicians working with external Qigong practitioners in the United States and China to develop a rigorous in vitro protocol for evaluating potential direct effects of external Qigong.
More complex and sophisticated models of child-onset psychiatric disorders have been achieved by interdisciplinary collaborations between basic scientists and clinicians, such as the recent findings on specific gene-environment interactions.
Regarding mechanisms of endocrine resistance, collaboration between basic scientist, histopathologists and clinicians is warranted [ 72].
Another difference between a basic scientist and clinical research scientist in the pharmaceutical industry, particularly in a position with a CRO, is less freedom to work in a preferred area of research or therapeutic indication.
Research questions stemming from such a reexamination of disease emergence would demand close collaboration between basic scientists, clinicians, and the social scientists and epidemiologists who adopt such perspectives.
